Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure

28th September 2018 Uncategorised 0

Days after swinging the ax on 400 R&D jobs in China and Denmark, diabetes giant Novo Nordisk is laying off again—this time in the U.S.

More: Novo Nordisk to slash 250 U.S. jobs in the face of ongoing pricing pressure
Source: fierce